Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

COX2

  • You have access
    Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
    KUNIHIKO KOBAYASHI, KYOICHI KAIRA and HIROSHI KAGAMU
    Anticancer Research September 2020, 40 (9) 5309-5311; DOI: https://doi.org/10.21873/anticanres.14537
  • You have access
    Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer
    KATSUHIKO SHIMIZU, RIKI OKITA, SHINSUKE SAISHO, AI MAEDA, YUJI NOJIMA and MASAO NAKATA
    Anticancer Research August 2018, 38 (8) 4637-4644; DOI: https://doi.org/10.21873/anticanres.12768
  • You have access
    COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients
    PATRICIA DE CREMOUX, ANNE-SOPHIE HAMY, JACQUELINE LEHMANN-CHE, VÉRONIQUE SCOTT, BRIGITTE SIGAL, MARIE-CHRISTINE MATHIEU, PHILIPPE BERTHEAU, JEAN MARC GUINEBRETIÈRE, JEAN YVES PIERGA, SYLVIE GIACCHETTI, ETIENNE BRAIN, MICHEL MARTY, BERNARD ASSELAIN, FRÉDÉRIQUE SPYRATOS and IVAN BIÈCHE
    Anticancer Research March 2018, 38 (3) 1485-1490;
  • You have access
    Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer
    WEN-SHIN CHANG, CHENG-HSI LIAO, CHIN-MU HSU, CHUNG-YU HUANG, HSIN-YUAN FANG, PEI-YU KAO, CHIA-WEN TSAI, HSI-CHIN WU, PEI-SHIN HU, TZU-CHIA WANG, YUN-RU SYU, HAO-AI SHUI and DA-TIAN BAU
    Anticancer Research May 2015, 35 (5) 2725-2730;
  • You have access
    The Role of Functional Polymorphisms of Cyclooxygenase 2 in Renal Cell Carcinoma
    WEN-SHIN CHANG, CHENG-HSI LIAO, CHIA-EN MIAO, HSI-CHIN WU, LIN-LIN HOU, CHIEH-LUN HSIAO, HONG-XUE JI, CHIA-WEN TSAI and DA-TIAN BAU
    Anticancer Research October 2014, 34 (10) 5481-5486;
  • You have access
    Prognostic Markers in Early-stage Colorectal Cancer: Significance of TYMS mRNA Expression
    ANNA KOUMARIANOU, IOANNA TZEVELEKI, DIMOSTHENIS MEKRAS, ANASTASIA G. ELEFTHERAKI, MATTHEOS BOBOS, RALPH WIRTZ, ELENA FOUNTZILAS, CHRISTOS VALAVANIS, IOANNIS XANTHAKIS, KONSTANTINE T. KALOGERAS, GEORGE BASDANIS, GEORGE PENTHEROUDAKIS, VASSILIKI KOTOULA and GEORGE FOUNTZILAS
    Anticancer Research September 2014, 34 (9) 4949-4962;
  • You have access
    Endoplasmic Reticulum Stress Response as a Possible Mechanism of Cyclooxygenase-2-independent Anticancer Effect of Celecoxib
    WONJAE CHA, SEOK-WOO PARK, TACK-KYUN KWON, J. HUN HAH and MYUNG-WHUN SUNG
    Anticancer Research April 2014, 34 (4) 1731-1735;
  • You have access
    COX2 Inhibitor NS398 Reduces HT-29 Cell Invasiveness by Modulating Signaling Pathways Mediated by EGFR and HIF1-α
    CLAUDIA BOCCA, FRANCESCA BOZZO and ANTONELLA MIGLIETTA
    Anticancer Research April 2014, 34 (4) 1793-1800;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire